I agree that this site is using cookies. You can find further informations here.
X
Tugnait, Meera
24  results:
Search for persons X
?
1

Evaluation of the drug–drug interaction potential of brigat..:

Hanley, Michael J. ; Yeo, Karen Rowland ; Tugnait, Meera...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  4 - p. 624-637 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Discovery of mobocertinib, a potent, oral inhibitor of EGFR..:

Huang, Wei-Sheng ; Li, Feng ; Gong, Yongjin...
Bioorganic & Medicinal Chemistry Letters.  80 (2023)  - p. 129084 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Brigatinib pharmacokinetics in patients with chronic hepati..:

Hanley, Michael J. ; Kerstein, David ; Tugnait, Meera...
Investigational New Drugs.  41 (2023)  3 - p. 402-410 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Effect of severe renal impairment on the pharmacokinetics o..:

Gupta, Neeraj ; Hanley, Michael J. ; Kerstein, David...
Investigational New Drugs.  39 (2021)  5 - p. 1306-1314 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Safety and efficacy of avapritinib in advanced systemic mas..:

DeAngelo, Daniel J. ; Radia, Deepti H. ; George, Tracy I....
Nature Medicine.  27 (2021)  12 - p. 2183-2191 , 2021
Link: https://doi.org/10.1038/..
 
?
6

Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Indu..:

Tugnait, Meera ; Gupta, Neeraj ; Hanley, Michael J....
Clinical Pharmacology in Drug Development.  9 (2019)  2 - p. 214-223 , 2019
Link: https://doi.org/10.1002/..
 
?
7

The Effect of a High‐Fat Meal on the Pharmacokinetics of Br..:

Tugnait, Meera ; Gupta, Neeraj ; Hanley, Michael J....
Clinical Pharmacology in Drug Development.  8 (2018)  6 - p. 734-741 , 2018
Link: https://doi.org/10.1002/..
 
?
8

Ponatinib in Japanese patients with Philadelphia chromosome..:

Tojo, Arinobu ; Kyo, Taiichi ; Yamamoto, Kazuhito...
International Journal of Hematology.  106 (2017)  3 - p. 385-397 , 2017
Link: https://doi.org/10.1007/..
 
?
9

PF-03882845, a non-steroidal mineralocorticoid receptor ant..:

Orena, Stephen ; Maurer, Tristan S. ; She, Li...
Frontiers in Pharmacology.  4 (2013)  - p. , 2013
Link: https://doi.org/10.3389/..
 
?
10

Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT..:

Maurer, Tristan S. ; Ghosh, Avijit ; Haddish-Berhane, Nahor...
The AAPS Journal.  13 (2011)  4 - p. 576-584 , 2011
Link: https://doi.org/10.1208/..
 
?
11

Discovery of a Clinical Candidate from the Structurally Uni..:

Mascitti, Vincent ; Maurer, Tristan S. ; Robinson, Ralph P....
Journal of Medicinal Chemistry.  54 (2011)  8 - p. 2952-2960 , 2011
Link: https://doi.org/10.1021/..
 
?
12

The use of plasma aldosterone and urinary sodium to potassi..:

Eudy, Rena J ; Sahasrabudhe, Vaishali ; Sweeney, Kevin...
Journal of Translational Medicine.  9 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
13

Metabolism and transporter-mediated drug–drug interactions ..:

Sahi, Jasminder ; Sinz, Michael W. ; Campbell, Scott...
Chemico-Biological Interactions.  159 (2006)  2 - p. 156-168 , 2006
Link: https://doi.org/10.1016/..
 
?
14

Application of semi-automated metabolite identification sof..:

Ramanathan, Ragu ; McKenzie, Donald L. ; Tugnait, Meera.
Journal of Pharmaceutical and Biomedical Analysis.  28 (2002)  5 - p. 945-951 , 2002
Link: https://doi.org/10.1016/..
 
?
15

Characterization of the human hepatic cytochromes P450 invo..:

Tugnait, Meera ; Hawes, Edward M. ; McKay, Gordon..
Chemico-Biological Interactions.  118 (1999)  2 - p. 171-189 , 1999
Link: https://doi.org/10.1016/..
 
1-15